Hypersalivation
There is currently a shortage of hyoscine tablets that is unlikely to resolve before April 2019. The attached memo contains information on alternatives:
Product Shortage Information: Hyoscine hydrobromide 150 and 300 microgram tablets
Only licensed for hypersalivation associated with clozapine therapy but approved for use with other antipsychotics by the trust
Recommended dose 150 - 300 micrograms up to 3 times a day
| Pack | Price |
|---|---|
| 12 tablet | £1.67 |
| Pack | Price |
|---|---|
| 12 tablet | £1.67 |
| Pack | Price |
|---|---|
| 12 tablet |
Unlicensed for this indication but approved for use by the trust
Sublingually or a 1mg/10ml solution used as a mouthwash
| Pack | Price |
|---|---|
| 10 ml | £132.25 |
| 5 ml |
This medication is not licensed in the UK but is approved for use by the trust
Dose: 50mg daily up to 50mg three times a day
| Pack | Price |
|---|---|
| 1 tablet |
| Pack | Price |
|---|---|
| 1 tablet |
Not licensed for this indication but approved for use by the trust
Dose: 2mg once a day. Slow increase of 2mg every 3 - 5 days recommended with twice or three times a day dosing. Up to 15mg daily
| Pack | Price |
|---|---|
| 100 tablet | |
| 84 tablet | £3.05 |
| Pack | Price |
|---|---|
| 100 tablet | |
| 84 tablet | £17.91 |
| Pack | Price |
|---|---|
| 200 ml | £22.00 |